Our Technology
To solve data gap in modern drug discovery, we build our proprietary screening platform Pandora that continuously generates massive amounts of protein-ligand interaction data across hundreds of drug targets
Pandora screening platform
10-50 Billion
data points of ligand-protein interactions per run
$1'000
cost
V/S
Pandora™ Drug Discovery Platform
Order of magnitude faster and cheaper HTS screening, 3-step optimization of activity and selectivity, unique molecular libraries in unexplored chemical space
01
Ligand generation
We use custom display technologies to continuously generate massive volumes of ligands in unexplored chemical space
02
Ligand-protein screening
We build custom cellular assays, split-systems and adaptive evolution methods to screen and optimize molecules for protein binding
03
Foundational AI models
We build AI to decode relevant patterns, translate them into better drugs and inform next cycles of ligands generation and screening
Our Pipeline
Leveraging our platform to target undruggable and hard-to-drug proteins to address unmet medical needs in oncology and immunology
Undisclosed 1
Undisclosed 2
Undisclosed 3
Oncology
Immunology
Immunology
Undisclosed target 1
-
First Oral Therapy Targeting a Hallmark Inflammatory Pathway
-
Addresses Significant Patient Need in a $25B IBD/UC Market
-
Differentiated Product Enhancing Convenience and Compliance
Undisclosed target 2
-
First Oral Agent Reactivating a Key Tumor Suppressor Pathway
-
Addresses High Unmet Need in Resistant Cancers
-
Targeted Therapy Offering Improved Safety and Efficacy
Undisclosed target 3
-
First-in-Class Inhibitor of a Key Oncogenic Adapter Protein
-
Addresses High Unmet Need in Aggressive Cancers
-
Novel Approach Overcoming "Undruggable" Protein Interactions
Contact Us
Contact Information
Address
JLABS @ BE, Janssen Pharmaceutica NV Beerse Site 1, Turnhoutseweg 30, 2340 Beerse